Cipla, on Tuesday, announced the commercialisation of its real-time COVID-19 RT-PCR test kit in India. The ‘RT-Direct’ multiplex COVID-19 RT PCR test kit will be released in partnership with Genes2Me ...

The RT-Direct multiplex COVID-19 RT-PCR kit is validated by the Indian Council of Medical Research (ICMR) is much more advanced than other test kits, the drug firm said. Cipla will be responsible for ...

Real-time polymerase chain reaction reverse transcription (RT-qPCR) has been described as the gold standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. While the ...

RT- Direct Multiplex RTPCR kit for COVID-19 kit is based on Gold standard RTPCR method with coverage of 3 target genes specific to SARS-COV-2 along with IC, which is much advanced than all others ...

The dry swab-direct RT-PCR testing method is aimed at scaling up the testing by two to three fold(AP) The Indian Council of Medical Research (ICMR) has approved a dry swab-direct RT-PCR testing method ...

Picture for representation. Cipla will be responsible for the distribution of RT Direct kits in India and has commenced supply of the same, it added.(AP) Cipla launched real time RT-PCR test kit for ...

The scientists informed that if the virus doesn't attach to the cells, it can't enter and therefore dies (lifetime 1 to 5 hours). (File) Cipla Limited on Tuesday announced the commercialisation of ‘RT ...

Cipla announced the commercialisation of RT-Direct multiplex COVID-19 RT PCR Test kit in India, in partnership with Genes2Me Pvt. Ltd. With this Cipla is expanding its diagnostics offering to bring ...

Cipla Limited on Tuesday has announced the commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR Test kit in India, in partnership with Genes2Me Pvt. Ltd. With this Cipla is expanding its ...